HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Alcohol Use Disorder

In brief

The purpose of this study is to determine whether gabapentin enacarbil is effective in the treatment of problems with alcohol.

Key facts

Study ID

NCT02252536

Run by

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

People needed

346

Starts

2015-06-01

Expected to finish

2017-03-01

Last updated by the study team

2018-11-14

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must meet each one of the following inclusion criteria in order to be eligible for participation in the study:
• Be at least 21 years of age.
• Have a current (past 12 months) DSM-5 diagnosis of AUD.
• Have a BAC by breathalyzer equal to 0.000 when s/he signed the informed consent document (either just prior to or immediately after signing consent).
• Be seeking treatment for problems with alcohol.
• Additional will be evaluated in clinic.

You may not qualify if…

• Evaluations will be conducted in clinic.

Where it is running

• University of California Los Angeles — Los Angeles, California, United States
• Friends Research Institute — San Francisco, California, United States
• University of Miami, Miller School of Medicine — Miami, Florida, United States
• Johns Hopkins University School of Medicine — Baltimore, Maryland, United States
• Boston University Medical Center — Boston, Massachusetts, United States
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
• Mount Sinai St. Luke's Hospital — New York, New York, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• The University of Texas Southwestern Medical Center — Dallas, Texas, United States
• University of Virginia — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.